Mireille Gillings

Mireille Gillings, PhD, Hon DSc
CEO and Executive Chair

Dr. Gillings founded HUYA Bioscience International and has grown this privately-held company to become the global leader in accelerating the development of novel biopharmaceutical product opportunities originating in China in worldwide markets. She was the first to establish extensive collaborations with Chinese academic and commercial biopharmaceutical organizations for this purpose. Read More >

Bob Goodenow

Robert Goodenow, PhD

Dr. Goodenow has served at executive and senior management levels in multinational pharmaceutical and biotechnology companies, with roles in research and development, business development, and commercialization. He has a strong licensing track record, including global and regional transactions. Read More >

Clement Gingras

Clement Gingras
Chief Technology Officer and Chief Operating Officer Asia

Mr. Gingras is responsible for HUYA Bioscience International’s presence in Asia, which includes oversight of operations in China and Japan and the engagement strategy for the wider region. He also directs the company’s IT and technology development, focusing on the growth of the HUYABIO compound database, the world’s most comprehensive portfolio of Chinese pharmaceutical compounds. Read More >


Jonathan O’Connell
Chief Financial Officer

Mr. O’Connell has deep expertise and understanding of both the life science and technology industries, including leading fundraisings, public listings, acquisitions and trade sales. With over 25 years experience, Mr. O’Connell previously served as the CFO and Director of Escher Group Holdings, a listed technology company.  Read More >

Martin Doorbar

Martin Doorbar
Global Head CMC and Manufacturing Operations

Mr. Doorbar has extensive experience across all phases of drug and medical device development and manufacturing. This includes formulation and analytical development, process scale-up, product validation, technology transfer, quality control, manufacturing, materials management and product lifecycle oversight. Read More >